A venture capital firm based in the central US is currently in the process of raising its 2nd fund, targeted at $50 million. The firm typically makes equity co-investments in seed and early stage companies ranging from $50,000 to $8 million with most investments in the $250,000 to $1.5 million range. The firm typically makes 6-8 allocations per year, and is open to opportunities throughout the United States and Canada.
The firm is looking for companies in telemedicine, healthcare IT, pathology, diagnostics, bioinformatics, medical devices, and healthcare automation. The firm does not look at pharmaceutical opportunities. The firm is interested in early stage companies from pre-prototype or pre-clinical to clinical stage that have a cost efficient and innovative product with a clear pathway to exit in approximately 3-5 years. The firm is open to consider all indications and types of devices. The firm is not interested in late stage investments into companies that already have a product on the market. The firm focuses on opportunities that focus on patient care improvements, healthcare IT or products that solve critical problems that hospitals, doctors or patients face—and for which the company can receive reimbursement.
The firm is looking for entrepreneur-based management teams with experience who are open to work with them. The firm looks to take a board seat following investment. In addition to capital, the firm is capable of providing strategic mentoring as well as incubation services both locally and remotely in areas of HR, Marketing, Accounting and Software Development.
If you are interested in more information about this investor and other investors tracked by LSN, please email email@example.com